2021 EAEU regulatory changes January 15, 2021

2021 EAEU regulatory changes

Are you ready for 2021 EAEU regulatory changes?

Effective as of January 10, 2021, the registration of medicines in the Russian Federation carries out only in accordance with EAEU rules (Decision of the EEC Council No. 128 of December 23, 2020).

For other EAEU countries, the registration of medicines under national procedures has been extended until July 1, 2021.

Inpharmatis is an international consulting company with more than 15 years’ experience in EAEU, CIS, and EU markets in the field of regulatory services for pharmaceutical companies.

If you want to find out more information about EAEU registration rules, please contact us at info@inpharmatis.com.